Directors

Chris Mirabelli, (Chairman) Health Care Ventures

Denis Lucquin, Sofinnova Partners

Edward Connor, M.D., MedImmune Ventures

Dan Kisner, Aberdare Ventures

Dave Summa, Acumen Pharmaceuticals

Julie Eskay-Eagle, Wellcome Trust

Steven Skolsky, Sequoia Pharmaceuticals

John Erickson, Sequoia Pharmaceuticals

 

Julie Eskay-Eagle , The Wellcome Trust

Wellcome Trust logo

Ms. Eskay-Eagle manages September Ventures, and previously was a full-time employee of The Wellcome Trust in London, UK from 2001-2004 where she established a formal Direct Investment Program.  Prior to joining the Trust she was a Vice President with Lazard Freres in Health Care Investment Banking and a founding member of Lazard Technology Partners.  Before joining Lazard, she was a Health Care Specialist with McKinsey & Co. in New York. Ms. Eskay-Eagle has a bachelor’s degree in Biomedical Ethics from Cornell University and an MBA from Columbia University. 

www.wellcome.ac.uk